Internal Medicine, Endocrinology, Diabetes, & Metabolism · New Haven, CT
NPI
1093851321
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
200 Orchard St, #207
New Haven, CT, 06511
Phone (203) 776-4444
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
1,464 services
Medicare patients, 2024
261
Average age 75
Drug cost, 2024
$1.7M
3,195 prescriptions
Company payments, 2025
$629
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kai H Yang was code 99214 (office e&m - established), 209 times for 158 patients. In total Kai H Yang billed 1,464 services in 18 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 209 | 158 | $98.34 | $21K |
| 99213 Office E&M - Established | Office | 112 | 106 | $65.98 | $7,389 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 79 | 74 | $13.68 | $1,081 |
| 83036 Blood Count | Office | 42 | 35 | $9.52 | $400 |
| 82962 Clinical Chemistry | Office | 30 | 25 | $3.21 | $96.3 |
| 95251 Test - Miscellaneous | Office | 28 | 15 | $24.18 | $677 |
By year: 2022 $57K for 1,770 services; 2023 $53K for 1,403 services; 2024 $52K for 1,464 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 42 | 35 | $9.52 | $400 |
| 82962 Clinical Chemistry | 30 | 25 | $3.21 | $96.3 |
Medicare prescription drug claims, 2024
In 2024, the drug Kai H Yang prescribed most often to Medicare patients was Levothyroxine Sodium, with 439 prescriptions and refills. In total Kai H Yang wrote 3,195 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 439 | 1,281 | 136 | $4,853 |
| Metformin Hcl Er Metformin Hcl | 266 | 757 | 85 | $4,501 |
| Synthroid Levothyroxine Sodium | 261 | 767 | 79 | $30K |
| Ozempic Semaglutide | 259 | 554 | 67 | $540K |
| Levoxyl Levothyroxine Sodium | 151 | 410 | 45 | $4,560 |
| Unithroid Levothyroxine Sodium | 138 | 406 | 38 | $4,212 |
| Metformin Hcl Generic | 119 | 294 | 29 | $873 |
| Jardiance Empagliflozin | 100 | 256 | 31 | $149K |
| Mounjaro Tirzepatide | 86 | 146 | 19 | $157K |
| Trulicity Dulaglutide | 68 | 158 | 21 | $158K |
| Methimazole Generic | 62 | 162 | 19 | $556 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 58 | 157 | 28 | $6,403 |
| Tresiba Flextouch U-200 Insulin Degludec | 54 | 122 | 14 | $83K |
| Tresiba Flextouch U-100 Insulin Degludec | 48 | 120 | 16 | $31K |
| Atorvastatin Calcium Generic | 47 | 141 | 15 | $333 |
Brand drugs: 1,706 claims; generic drugs: 1,323 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kai H Yang $629 ($629 in general payments such as food, travel and fees) from 12 companies. The largest payer was Insulet Corporation with $207.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 8 | $207 |
| Mannkind Corporation MNKD | 2 | $75.2 |
| Sequel Med Tech, LLC | 3 | $64.97 |
| Novo Nordisk Inc NVO | 3 | $51.8 |
| Abbvie Inc. ABBV | 2 | $45.96 |
| Amgen Inc. AMGN | 2 | $43.03 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $30.99 |
| Almatica Pharma LLC | 1 | $26.22 |
| Lilly USA, LLC LLY | 1 | $25.96 |
| Abbott Laboratories ABT | 1 | $23.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.